Posted by Michael Wonder on 09 Aug 2022
Network collaborators announced for CADTH’s post-market drug evaluation network
8 August 2022 - CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation Network.
Collaborators will bring additional expertise to the Post-Market Drug Evaluation Network Network and will respond to decision-makers’ queries by providing expertise and evidence in the post-market space.
The Post-Market Drug Evaluation Network Program will launch 1 September 2022, and contracts will be issued to these individuals or teams as queries are received by the Post-Market Drug Evaluation Network Program.
